Joe Lopez

Joe Lopez is an experienced professional in the field of biologics and cell therapy, currently serving as a QC Specialist 3 at CTMC, a joint venture between Resilience and MD Anderson Cancer Center, since May 2022. Previously, Joe worked as a Biologics Development Associate 3 at MD Anderson Cancer Center, conducting quality control release testing on therapeutics, and as a Senior Assay Development Associate at Bellicum Pharmaceuticals, focusing on validation assays for cell therapy products. Joe's career includes significant roles at AutoGenomics, Bristol-Myers Squibb, Medarex, and GenPharm International, contributing to the development of immunotherapies and recombinant antibodies. Joe holds a Bachelor's Degree in Chemistry from San Jose State University, obtained between 2008 and 2013.